High-dose epidoxorubicin (HDEDX), cisplatin (CDDP), Lonidamine (LND), alpha 2B interferon (IFN) in advanced breast cancer (ABC): preliminary results of a randomized phase II study / Iaffaioli, R.V., Santangelo, M.. - (1997). (VII International Congress on Anti-Cancer Treatment. Paris, 3-6 February 1997.).
High-dose epidoxorubicin (HDEDX), cisplatin (CDDP), Lonidamine (LND), alpha 2B interferon (IFN) in advanced breast cancer (ABC): preliminary results of a randomized phase II study.
SANTANGELO, MICHELE
1997
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
